首页 > 最新文献

Malaysian Family Physician最新文献

英文 中文
Association of symptoms and comorbidities with hospitalization among patients infected with coronavirus disease : A cross-sectional study among users of Universitas Sumatera Utara's COVID-19 Telemedicine. 冠状病毒感染患者的症状和合并症与住院的关系:苏门答腊北方大学COVID-19远程医疗用户的横断面研究
Q3 Nursing Pub Date : 2025-09-11 eCollection Date: 2025-01-01 DOI: 10.51866/oa.329
Albert Tanaka, Isti Ilmiati Fujiati

Introduction: Coronavirus disease (COVID-19) is a highly contagious disease caused by severe acute respiratory syndrome coronavirus 2 and was declared by the World Health Organization as a pandemic on 11 March 2020. However, COVID-19 will continue to occur in the future. Therefore, this research aimed to determine the factors that affect the risk of hospitalisation of patients infected with COVID-19 so that preventive measures can be taken promptly.

Methods: This study adopted a descriptive, analytic, cross-sectional research design. The sample included the people of North Sumatra who used Universitas Sumatera Utara's COVID-19 Telemedicine and met the research criteria. The data were analysed using the chi-square test, with odds ratios (ORs) calculated.

Results: Among the clinical symptoms of the patients, runny nose (OR=10.9), sore throat (OR=23.5), muscle pain (OR=24.3), headache (OR=33.7), diarrhoea (OR=7.7), nausea (OR=10.6), vomiting (OR=4.4), ageusia (OR=6.3) and anosmia (OR=5.5) were more commonly associated with an increased risk of hospitalisation. Among the comorbidities, hypertension (OR=2.5) and diabetes (OR=4.9) increased the risk of hospitalisation.

Conclusion: Runny nose, sore throat, muscle pain, headache, diarrhoea, nausea, vomiting, ageusia, anosmia, diabetes and hypertension are associated with an increased risk of hospitalisation among patients with COVID-19.

简介:冠状病毒病(COVID-19)是由严重急性呼吸系统综合征冠状病毒2引起的高度传染性疾病,世界卫生组织于2020年3月11日宣布为大流行。然而,COVID-19将在未来继续发生。因此,本研究旨在确定影响COVID-19患者住院风险的因素,以便及时采取预防措施。方法:本研究采用描述性、分析性、横断面研究设计。样本包括使用北苏门答腊大学COVID-19远程医疗并符合研究标准的北苏门答腊人。采用卡方检验对数据进行分析,并计算优势比(or)。结果:在患者的临床症状中,流鼻涕(OR=10.9)、喉咙痛(OR=23.5)、肌肉痛(OR=24.3)、头痛(OR=33.7)、腹泻(OR=7.7)、恶心(OR=10.6)、呕吐(OR=4.4)、衰老(OR=6.3)和嗅觉丧失(OR=5.5)与住院风险增加的相关性更为常见。在合并症中,高血压(OR=2.5)和糖尿病(OR=4.9)增加了住院的风险。结论:流鼻涕、喉咙痛、肌肉痛、头痛、腹泻、恶心、呕吐、老年痴呆、嗅觉丧失、糖尿病和高血压与COVID-19患者住院风险增加有关。
{"title":"Association of symptoms and comorbidities with hospitalization among patients infected with coronavirus disease : A cross-sectional study among users of Universitas Sumatera Utara's COVID-19 Telemedicine.","authors":"Albert Tanaka, Isti Ilmiati Fujiati","doi":"10.51866/oa.329","DOIUrl":"10.51866/oa.329","url":null,"abstract":"<p><strong>Introduction: </strong>Coronavirus disease (COVID-19) is a highly contagious disease caused by severe acute respiratory syndrome coronavirus 2 and was declared by the World Health Organization as a pandemic on 11 March 2020. However, COVID-19 will continue to occur in the future. Therefore, this research aimed to determine the factors that affect the risk of hospitalisation of patients infected with COVID-19 so that preventive measures can be taken promptly.</p><p><strong>Methods: </strong>This study adopted a descriptive, analytic, cross-sectional research design. The sample included the people of North Sumatra who used Universitas Sumatera Utara's COVID-19 Telemedicine and met the research criteria. The data were analysed using the chi-square test, with odds ratios (ORs) calculated.</p><p><strong>Results: </strong>Among the clinical symptoms of the patients, runny nose (OR=10.9), sore throat (OR=23.5), muscle pain (OR=24.3), headache (OR=33.7), diarrhoea (OR=7.7), nausea (OR=10.6), vomiting (OR=4.4), ageusia (OR=6.3) and anosmia (OR=5.5) were more commonly associated with an increased risk of hospitalisation. Among the comorbidities, hypertension (OR=2.5) and diabetes (OR=4.9) increased the risk of hospitalisation.</p><p><strong>Conclusion: </strong>Runny nose, sore throat, muscle pain, headache, diarrhoea, nausea, vomiting, ageusia, anosmia, diabetes and hypertension are associated with an increased risk of hospitalisation among patients with COVID-19.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"56"},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12510772/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and risk factors of preterm birth among pregnant adolescents in Kuala Lumpur: A cross-sectional study. 吉隆坡怀孕青少年早产的患病率和危险因素:一项横断面研究。
Q3 Nursing Pub Date : 2025-09-11 eCollection Date: 2025-01-01 DOI: 10.51866/oa.711
Nur Aznida Abu Bakar, Dalila Roslan, Nik Nairan Abdullah, Musbahiyah Mat Zainal, Pillai Simon Puvanese Rebecca

Introduction: Adolescent pregnancies are often associated with a higher risk of adverse outcomes, including preterm birth, which may lead to severe physiological and psychological health impacts on both mothers and children. Despite the acknowledged risks, there is a knowledge gap regarding the risk factors of preterm birth among pregnant adolescents. This study aimed to determine the prevalence and associated sociodemographic, maternal, intrapartum and neonatal factors of preterm birth among pregnant adolescents in Kuala Lumpur.

Methods: A cross-sectional study was conducted in Kuala Lumpur, Malaysia, from March to June 2024. Samples were selected using simple random sampling from the Wilayah Persekutuan Kuala Lumpur and Putrajaya Department of Health pregnant adolescents' line listing from 2019 to 2023. Simple and multiple logistic regression analyses were used to determine the factors associated with preterm birth.

Results: A total of 175 pregnant adolescents were included in the study. The prevalence of preterm birth was 16%. Anaemia at booking (adjusted odds ratio [aOR]: 7.8; 95% confidence interval [CI]: 2.53, 23.997), history of preterm birth (aOR: 11.654; 95% CI: 1.517, 89.498), history of smoking (aOR: 6.89; 95% CI: 1.397, 34.002) and low birth weight (aOR: 12.503; 95% CI: 3.858, 40.522) were significantly associated with preterm birth.

Conclusion: Targeted interventions to address anaemia, history of smoking, previous history of preterm births and low birth weight babies in adolescent pregnancies are crucial to reduce the incidence of preterm birth and improve maternal and infant health outcomes in this population among adolescents.

导言:少女怀孕往往与包括早产在内的不良后果风险较高有关,这可能对母亲和儿童造成严重的生理和心理健康影响。尽管存在公认的风险,但对怀孕少女早产的风险因素仍存在知识差距。本研究旨在确定吉隆坡怀孕青少年中早产的患病率和相关的社会人口学、产妇、产时和新生儿因素。方法:于2024年3月至6月在马来西亚吉隆坡进行横断面研究。样本采用简单随机抽样的方法,从吉隆坡和布城卫生局2019年至2023年怀孕少女名单中选择。使用简单和多元逻辑回归分析来确定与早产相关的因素。结果:本研究共纳入175名怀孕少女。早产率为16%。产前贫血(校正优势比[aOR]: 7.8; 95%可信区间[CI]: 2.53, 23.997)、早产史(aOR: 11.654; 95% CI: 1.517, 89.498)、吸烟史(aOR: 6.89; 95% CI: 1.397, 34.002)和低出生体重(aOR: 12.503; 95% CI: 3.858, 40.522)与早产显著相关。结论:针对青少年妊娠中贫血、吸烟史、早产史和低出生体重儿的针对性干预措施对于降低该人群的早产发生率和改善母婴健康结局至关重要。
{"title":"Prevalence and risk factors of preterm birth among pregnant adolescents in Kuala Lumpur: A cross-sectional study.","authors":"Nur Aznida Abu Bakar, Dalila Roslan, Nik Nairan Abdullah, Musbahiyah Mat Zainal, Pillai Simon Puvanese Rebecca","doi":"10.51866/oa.711","DOIUrl":"10.51866/oa.711","url":null,"abstract":"<p><strong>Introduction: </strong>Adolescent pregnancies are often associated with a higher risk of adverse outcomes, including preterm birth, which may lead to severe physiological and psychological health impacts on both mothers and children. Despite the acknowledged risks, there is a knowledge gap regarding the risk factors of preterm birth among pregnant adolescents. This study aimed to determine the prevalence and associated sociodemographic, maternal, intrapartum and neonatal factors of preterm birth among pregnant adolescents in Kuala Lumpur.</p><p><strong>Methods: </strong>A cross-sectional study was conducted in Kuala Lumpur, Malaysia, from March to June 2024. Samples were selected using simple random sampling from the Wilayah Persekutuan Kuala Lumpur and Putrajaya Department of Health pregnant adolescents' line listing from 2019 to 2023. Simple and multiple logistic regression analyses were used to determine the factors associated with preterm birth.</p><p><strong>Results: </strong>A total of 175 pregnant adolescents were included in the study. The prevalence of preterm birth was 16%. Anaemia at booking (adjusted odds ratio [aOR]: 7.8; 95% confidence interval [CI]: 2.53, 23.997), history of preterm birth (aOR: 11.654; 95% CI: 1.517, 89.498), history of smoking (aOR: 6.89; 95% CI: 1.397, 34.002) and low birth weight (aOR: 12.503; 95% CI: 3.858, 40.522) were significantly associated with preterm birth.</p><p><strong>Conclusion: </strong>Targeted interventions to address anaemia, history of smoking, previous history of preterm births and low birth weight babies in adolescent pregnancies are crucial to reduce the incidence of preterm birth and improve maternal and infant health outcomes in this population among adolescents.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"60"},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12510770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with home blood pressure monitoring practices among patients with hypertension in Putrajaya, Malaysia: A cross-sectional study. 马来西亚布城高血压患者家庭血压监测相关因素:一项横断面研究。
Q3 Nursing Pub Date : 2025-09-11 eCollection Date: 2025-01-01 DOI: 10.51866/oa.889
Luqman Melissha, Siew Mooi Ching, Mohamad Fadzilah, Hanum Mohd Yusof Hazira

Introduction: This study primarily aimed to determine the factors associated with home blood pressure monitoring (HBPM) practices among patients with hypertension in Putrajaya, Malaysia.

Methods: A cross-sectional study was conducted among patients with hypertension aged 18 years and above in a government health clinic in Putrajaya. An adopted and validated questionnaire on the knowledge, attitude and practice of HBPM was utilised. A total of 338 patients with hypertension were recruited.

Results: The median age of the participants was 52 years. Approximately 95.3%, 87.3%, 61.2%, 54.4% and 49.4% were Malay, were married, completed tertiary education, were men and were government servants, respectively. The prevalence of good HBPM knowledge, good attitude towards HBPM and HBPM practice among the participants was 79.0%, 57.1% and 81.7%, respectively. Having medical insurance (adjusted odds ratio [aOR]: 3.05, 95% confidence interval (CI): 1.47- 6.29, P=0.003), having diabetes mellitus (DM) (aOR: 4.58, 95% CI: 2.47-8.49, P<0.01), staying with household members (aOR: 2.95, 95% CI: 1.07-8.10, P=0.036), being a non-smoker (aOR: 3.72, 95% CI: 1.41-9.80, P=0.008) and engaging in physical activity (aOR: 2.47, 95% CI: 1.314.65, P=0.005) showed significant associations with HBPM practice.

Conclusion: The knowledge and practice of HBPM among patients with hypertension in Putrajaya, Malaysia, were excellent. The significant associated factors of HBPM practice were having medical insurance, having DM, staying with household members, being a non-smoker and being physically active. This study should be extended to the whole nation to obtain a true reflection of HBPM practice among Malaysians.

本研究主要旨在确定马来西亚布城高血压患者家庭血压监测(HBPM)实践的相关因素。方法:对布城一家政府卫生诊所18岁及以上的高血压患者进行横断面研究。采用一份经过验证的问卷,对HBPM的知识、态度和实践进行调查。总共招募了338名高血压患者。结果:参与者的中位年龄为52岁。大约95.3%、87.3%、61.2%、54.4%和49.4%分别是马来人、已婚、完成高等教育、男性和政府公务员。受访者对HBPM有良好的知识、良好的态度和实施HBPM的比例分别为79.0%、57.1%和81.7%。有医疗保险(调整优势比[aOR]: 3.05, 95%可信区间(CI): 1.47 ~ 6.29, P=0.003),有糖尿病(DM) (aOR: 4.58, 95% CI: 2.47 ~ 8.49, P)结论:马来西亚布城高血压患者HBPM知识和实践情况良好。HBPM实践的显著相关因素是有医疗保险、有糖尿病、与家庭成员住在一起、不吸烟和体育锻炼。这项研究应该扩展到全国,以获得马来西亚人HBPM实践的真实反映。
{"title":"Factors associated with home blood pressure monitoring practices among patients with hypertension in Putrajaya, Malaysia: A cross-sectional study.","authors":"Luqman Melissha, Siew Mooi Ching, Mohamad Fadzilah, Hanum Mohd Yusof Hazira","doi":"10.51866/oa.889","DOIUrl":"10.51866/oa.889","url":null,"abstract":"<p><strong>Introduction: </strong>This study primarily aimed to determine the factors associated with home blood pressure monitoring (HBPM) practices among patients with hypertension in Putrajaya, Malaysia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among patients with hypertension aged 18 years and above in a government health clinic in Putrajaya. An adopted and validated questionnaire on the knowledge, attitude and practice of HBPM was utilised. A total of 338 patients with hypertension were recruited.</p><p><strong>Results: </strong>The median age of the participants was 52 years. Approximately 95.3%, 87.3%, 61.2%, 54.4% and 49.4% were Malay, were married, completed tertiary education, were men and were government servants, respectively. The prevalence of good HBPM knowledge, good attitude towards HBPM and HBPM practice among the participants was 79.0%, 57.1% and 81.7%, respectively. Having medical insurance (adjusted odds ratio [aOR]: 3.05, 95% confidence interval (CI): 1.47- 6.29, P=0.003), having diabetes mellitus (DM) (aOR: 4.58, 95% CI: 2.47-8.49, P<0.01), staying with household members (aOR: 2.95, 95% CI: 1.07-8.10, P=0.036), being a non-smoker (aOR: 3.72, 95% CI: 1.41-9.80, P=0.008) and engaging in physical activity (aOR: 2.47, 95% CI: 1.314.65, P=0.005) showed significant associations with HBPM practice.</p><p><strong>Conclusion: </strong>The knowledge and practice of HBPM among patients with hypertension in Putrajaya, Malaysia, were excellent. The significant associated factors of HBPM practice were having medical insurance, having DM, staying with household members, being a non-smoker and being physically active. This study should be extended to the whole nation to obtain a true reflection of HBPM practice among Malaysians.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"61"},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12510775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: 'Postgraduate family medicine training in Southeast Asia' by Wattanapisit et al. (2025). 回复:Wattanapisit等人的“东南亚研究生家庭医学培训”(2025)。
Q3 Nursing Pub Date : 2025-09-02 eCollection Date: 2025-01-01 DOI: 10.51866/lte.979
Schawanya Kaewpitoon Rattanapitoon, Chutharat Thanchonnang, Nathkapach Kaewpitoon Rattanapitoon
{"title":"Reply to: 'Postgraduate family medicine training in Southeast Asia' by Wattanapisit et al. (2025).","authors":"Schawanya Kaewpitoon Rattanapitoon, Chutharat Thanchonnang, Nathkapach Kaewpitoon Rattanapitoon","doi":"10.51866/lte.979","DOIUrl":"10.51866/lte.979","url":null,"abstract":"","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"63"},"PeriodicalIF":0.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12510771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glycogenic hepatopathy - An underrecognised cause of transaminitis in primary care settings: A case report. 糖原性肝病-初级保健机构中未被充分认识的转氨炎病因:一个病例报告。
Q3 Nursing Pub Date : 2025-08-27 eCollection Date: 2025-01-01 DOI: 10.51866/cr.926
Zainul Abidin Nordiyana, Ying Ying Ng, Zakaria Rosnani, Samsuddin Noor Aellmas

Glycogenic hepatopathy (GH) is a rare but reversible hepatic condition associated with poorly controlled type 1 diabetes mellitus (T1DM). It results from excessive glycogen accumulation in hepatocytes, leading to hepatomegaly and elevated liver enzyme levels. We report the case of a 28-year-old man with T1DM who presented to a primary care clinic with persistent transaminitis despite discontinuation of potential hepatotoxic agents. Extensive investigations were conducted to exclude common liver pathologies, all of which returned negative. His condition improved following the intensification of insulin therapy and improvement of glycaemic control. This case underscores the role of family physicians in recognising GH as a differential diagnosis in patients with diabetes mellitus with unexplained liver enzyme abnormalities. It also highlights the importance of timely interventions to prevent unnecessary invasive investigations. Early recognition and appropriate glycaemic management in primary care can reverse the condition and minimise the need for extensive testing.

糖原性肝病(GH)是一种罕见但可逆的肝病,与控制不良的1型糖尿病(T1DM)相关。它是由肝细胞中过量的糖原积累引起的,导致肝肿大和肝酶水平升高。我们报告一例28岁的男性T1DM患者,尽管停用了潜在的肝毒性药物,但仍以持续性转氨炎就诊于初级保健诊所。进行了广泛的调查,以排除常见的肝脏病变,所有结果均为阴性。随着胰岛素治疗的加强和血糖控制的改善,病情有所改善。本病例强调了家庭医生在糖尿病伴不明原因肝酶异常的患者中将GH作为鉴别诊断的作用。它还强调了及时干预以防止不必要的侵入性调查的重要性。在初级保健中及早发现和适当的血糖管理可以扭转病情,并尽量减少广泛检测的需要。
{"title":"Glycogenic hepatopathy - An underrecognised cause of transaminitis in primary care settings: A case report.","authors":"Zainul Abidin Nordiyana, Ying Ying Ng, Zakaria Rosnani, Samsuddin Noor Aellmas","doi":"10.51866/cr.926","DOIUrl":"10.51866/cr.926","url":null,"abstract":"<p><p>Glycogenic hepatopathy (GH) is a rare but reversible hepatic condition associated with poorly controlled type 1 diabetes mellitus (T1DM). It results from excessive glycogen accumulation in hepatocytes, leading to hepatomegaly and elevated liver enzyme levels. We report the case of a 28-year-old man with T1DM who presented to a primary care clinic with persistent transaminitis despite discontinuation of potential hepatotoxic agents. Extensive investigations were conducted to exclude common liver pathologies, all of which returned negative. His condition improved following the intensification of insulin therapy and improvement of glycaemic control. This case underscores the role of family physicians in recognising GH as a differential diagnosis in patients with diabetes mellitus with unexplained liver enzyme abnormalities. It also highlights the importance of timely interventions to prevent unnecessary invasive investigations. Early recognition and appropriate glycaemic management in primary care can reverse the condition and minimise the need for extensive testing.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"57"},"PeriodicalIF":0.0,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432340/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case scenario: Management of sexually transmitted infections in primary care based on the fifth edition of the Malaysian guidelines. 案例情景:基于马来西亚指南第五版的初级保健性传播感染管理。
Q3 Nursing Pub Date : 2025-08-23 eCollection Date: 2025-01-01 DOI: 10.51866/cpg.916
Zainal Fitri Zakaria, Rupinder Kaur

Sexually transmitted infections (STIs) have a profound effect on sexual and reproductive health, with an estimated 374 million new infections reported globally in 2020. Most STI cases are likely to be presented at primary care clinics, making it crucial for primary care doctors to possess a strong understanding of STIs. Effective management of these infections relies on timely and accurate diagnosis, evidence-based treatment and comprehensive prevention strategies. The Malaysian Guidelines for the Management of Sexually Transmitted Infections Fifth Edition 2024 highlight the importance of treatment, prevention strategies and diagnostic recommendations, underscoring the role of primary care in addressing STIs effectively.

性传播感染对性健康和生殖健康产生深远影响,2020年全球报告的新感染人数估计为3.74亿。大多数性传播感染病例很可能出现在初级保健诊所,因此初级保健医生对性传播感染有深刻的了解至关重要。这些感染的有效管理依赖于及时准确的诊断、循证治疗和综合预防战略。马来西亚性传播感染管理指南第五版2024强调了治疗、预防战略和诊断建议的重要性,强调了初级保健在有效解决性传播感染方面的作用。
{"title":"Case scenario: Management of sexually transmitted infections in primary care based on the fifth edition of the Malaysian guidelines.","authors":"Zainal Fitri Zakaria, Rupinder Kaur","doi":"10.51866/cpg.916","DOIUrl":"10.51866/cpg.916","url":null,"abstract":"<p><p>Sexually transmitted infections (STIs) have a profound effect on sexual and reproductive health, with an estimated 374 million new infections reported globally in 2020. Most STI cases are likely to be presented at primary care clinics, making it crucial for primary care doctors to possess a strong understanding of STIs. Effective management of these infections relies on timely and accurate diagnosis, evidence-based treatment and comprehensive prevention strategies. The Malaysian Guidelines for the Management of Sexually Transmitted Infections Fifth Edition 2024 highlight the importance of treatment, prevention strategies and diagnostic recommendations, underscoring the role of primary care in addressing STIs effectively.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"59"},"PeriodicalIF":0.0,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145065997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognosis of patients with coronavirus disease with or without anosmia: A systematic review. 冠状病毒病伴或不伴嗅觉丧失患者的预后:一项系统综述
Q3 Nursing Pub Date : 2025-08-16 eCollection Date: 2025-01-01 DOI: 10.51866/rv.672
Nabeel Ibraheem Jaafar Albazah, Jie Sin Tiong, Muruganand Yoshana, Azma Aishath, Yu Tzong Yeo, Sherreen Elhariri

Introduction: According to numerous research, anosmia has been reported more frequently as one of coronavirus disease (COVID-19) symptoms. However, whether anosmia is a relevant prognostic factor of COVID-19 outcomes is still unknown. A systematic review and meta-analysis were conducted to evaluate the relationship between anosmia and COVID-19 prognosis.

Methods: PubMed, PubMed Central, Google Scholar and the WHO COVID-19 Research Database were scanned for published literature from September 2021 to December 2022 about the prognosis of patients positive for COVID-19 with anosmia. 'COVID-19' and 'prognosis' were among the search terms used. Pooled estimates of odds ratios (ORs) were then calculated by comparing patients with and without anosmia in terms of intensive care unit (ICU) admission and death.

Results: A total of 16 full-text articles were included in this systematic review. There were a total of 40 deaths among the patients with olfactory dysfunction and 1681 deaths among those without olfactory dysfunction, with an OR of 0.19 (95% confidence interval: 0.10, 0.34; P<0.0001), indicating that the patients with COVID-19 with olfactory dysfunction had a decreased mortality rate.

Conclusion: The good prognosis of patients with COVID-19 with anosmia is demonstrated in our study by the low mortality rate in those with anosmia. However, there is no association between the prognosis and ICU admission among patients with COVID-19 with anosmia.

根据大量研究,嗅觉缺失被报道为冠状病毒病(COVID-19)的症状之一。然而,嗅觉缺失是否是COVID-19预后的相关预后因素尚不清楚。通过系统回顾和荟萃分析来评估嗅觉缺失与COVID-19预后的关系。方法:扫描PubMed、PubMed Central、谷歌Scholar和WHO COVID-19研究数据库,检索2021年9月至2022年12月关于COVID-19阳性嗅觉缺失患者预后的已发表文献。“COVID-19”和“预后”是使用的搜索词。然后通过比较有和没有嗅觉缺失的患者在重症监护病房(ICU)入院和死亡方面的情况来计算优势比(ORs)的汇总估计。结果:本系统综述共纳入16篇全文文章。嗅觉功能障碍患者共死亡40例,无嗅觉功能障碍患者死亡1681例,OR为0.19(95%可信区间:0.10,0.34)。结论:嗅觉障碍患者的低死亡率证明了新冠肺炎嗅觉障碍患者预后良好。然而,新冠肺炎嗅觉缺失患者的预后与入住ICU无相关性。
{"title":"Prognosis of patients with coronavirus disease with or without anosmia: A systematic review.","authors":"Nabeel Ibraheem Jaafar Albazah, Jie Sin Tiong, Muruganand Yoshana, Azma Aishath, Yu Tzong Yeo, Sherreen Elhariri","doi":"10.51866/rv.672","DOIUrl":"10.51866/rv.672","url":null,"abstract":"<p><strong>Introduction: </strong>According to numerous research, anosmia has been reported more frequently as one of coronavirus disease (COVID-19) symptoms. However, whether anosmia is a relevant prognostic factor of COVID-19 outcomes is still unknown. A systematic review and meta-analysis were conducted to evaluate the relationship between anosmia and COVID-19 prognosis.</p><p><strong>Methods: </strong>PubMed, PubMed Central, Google Scholar and the WHO COVID-19 Research Database were scanned for published literature from September 2021 to December 2022 about the prognosis of patients positive for COVID-19 with anosmia. 'COVID-19' and 'prognosis' were among the search terms used. Pooled estimates of odds ratios (ORs) were then calculated by comparing patients with and without anosmia in terms of intensive care unit (ICU) admission and death.</p><p><strong>Results: </strong>A total of 16 full-text articles were included in this systematic review. There were a total of 40 deaths among the patients with olfactory dysfunction and 1681 deaths among those without olfactory dysfunction, with an OR of 0.19 (95% confidence interval: 0.10, 0.34; P<0.0001), indicating that the patients with COVID-19 with olfactory dysfunction had a decreased mortality rate.</p><p><strong>Conclusion: </strong>The good prognosis of patients with COVID-19 with anosmia is demonstrated in our study by the low mortality rate in those with anosmia. However, there is no association between the prognosis and ICU admission among patients with COVID-19 with anosmia.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"54"},"PeriodicalIF":0.0,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145065986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recognising atypical presentations of benign acute childhood myositis: Insights from a case series and literature review. 识别良性急性儿童肌炎的非典型表现:来自病例系列和文献回顾的见解。
Q3 Nursing Pub Date : 2025-08-09 eCollection Date: 2025-01-01 DOI: 10.51866/cr.805
Syed Ahmed Zaki

Benign acute childhood myositis (BACM) is a rare, self-limiting inflammatory condition affecting the skeletal muscle, typically emerging during the early convalescent phase of viral infections. Most patients recover with bed rest, analgesics and adequate hydration. However, atypical presentations can sometimes lead to delayed diagnoses and unnecessary investigations. We report five cases of BACM with unusual presentations at admission: toe walking, crawling, delayed recovery, rhabdomyolysis and recurrence. All patients experienced favourable outcomes and complete recovery upon follow-up. This case series highlights the diverse presentations of BACM, emphasising the importance of increasing awareness for early diagnosis, reducing unnecessary workups and providing proper counselling for parents.

良性急性儿童肌炎(BACM)是一种罕见的,影响骨骼肌的自限性炎症,通常出现在病毒感染的早期恢复期。大多数患者通过卧床休息、镇痛药和充足的水合作用恢复。然而,不典型的表现有时会导致延迟诊断和不必要的调查。我们报告5例BACM在入院时有不寻常的表现:脚趾行走,爬行,延迟恢复,横纹肌溶解和复发。所有患者在随访中均获得良好的结果和完全恢复。本病例系列强调了BACM的不同表现,强调了提高早期诊断意识、减少不必要的检查和为家长提供适当咨询的重要性。
{"title":"Recognising atypical presentations of benign acute childhood myositis: Insights from a case series and literature review.","authors":"Syed Ahmed Zaki","doi":"10.51866/cr.805","DOIUrl":"10.51866/cr.805","url":null,"abstract":"<p><p>Benign acute childhood myositis (BACM) is a rare, self-limiting inflammatory condition affecting the skeletal muscle, typically emerging during the early convalescent phase of viral infections. Most patients recover with bed rest, analgesics and adequate hydration. However, atypical presentations can sometimes lead to delayed diagnoses and unnecessary investigations. We report five cases of BACM with unusual presentations at admission: toe walking, crawling, delayed recovery, rhabdomyolysis and recurrence. All patients experienced favourable outcomes and complete recovery upon follow-up. This case series highlights the diverse presentations of BACM, emphasising the importance of increasing awareness for early diagnosis, reducing unnecessary workups and providing proper counselling for parents.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"52"},"PeriodicalIF":0.0,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond graduation: The journey of a young family doctor in Malaysia. 毕业之后:马来西亚一位年轻家庭医生的旅程。
Q3 Nursing Pub Date : 2025-08-09 eCollection Date: 2025-01-01 DOI: 10.51866/mol.96y
Marina Antony Nicholson
{"title":"Beyond graduation: The journey of a young family doctor in Malaysia.","authors":"Marina Antony Nicholson","doi":"10.51866/mol.96y","DOIUrl":"10.51866/mol.96y","url":null,"abstract":"","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"53"},"PeriodicalIF":0.0,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432338/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suspected liraglutide (glucagon-like peptide-1 receptor agonist)-induced hyperthyroidism: A case report. 疑似利拉鲁肽(胰高血糖素样肽-1受体激动剂)诱导的甲亢1例报告。
Q3 Nursing Pub Date : 2025-08-07 eCollection Date: 2025-01-01 DOI: 10.51866/cr.886
Siti Nur Syakinah Md Sabudin, Lili Husniati Yaacob, Muhammad Rahmat Che Omar

Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is widely used for weight management and glycaemic control. While generally well-tolerated, various adverse effects have been reported. Thyroid dysfunction, particularly hyperthyroidism, is rare. This report describes the case of a 34-year-old woman with new-onset hyperthyroidism following liraglutide use for weight loss. The patient presented with worsening palpitations and insomnia after 3 weeks of liraglutide use. She had no prior thyroid disease or significant family history. Examination revealed sinus tachycardia with no goitre or tremors. Laboratory findings confirmed hyperthyroidism with a suppressed TSH level (0.03 mlU/L) and an elevated free T4 level (20.8 pmol/L). Thyrotropin receptor antibody was negative, ruling out Graves' disease. Liraglutide was discontinued, and the patient was treated with carbimazole and propranolol, resulting in symptom resolution and normalisation of thyroid function within weeks. Liraglutide-induced thyroid dysfunction is poorly understood. Possible mechanisms include GLP-1 receptor activity in thyroid tissue, disruption of the hypothalamic-pituitary-thyroid axis or inflammation of thyroid follicular cells. This case demonstrates a strong temporal association between liraglutide use and hyperthyroidism, which resolved upon drug discontinuation. Although thyroid dysfunction with GLP-1 RAs has been noted in preclinical studies, human data remain limited. This case highlights a rare adverse effect of liraglutide and underscores the need for vigilance when monitoring patients on GLP-1 RAs. Monitoring of thyroid function should be considered in symptomatic patients. Further research is warranted to better understand the underlying mechanisms and prevalence of GLP-1 RA-induced thyroid abnormalities.

利拉鲁肽是一种胰高血糖素样肽-1受体激动剂(GLP-1 RA),广泛用于体重管理和血糖控制。虽然一般耐受性良好,但已有各种不良反应的报道。甲状腺功能障碍,特别是甲状腺功能亢进,是罕见的。本报告描述了一例34岁妇女在利拉鲁肽用于减肥后新发甲状腺功能亢进。患者使用利拉鲁肽3周后出现心悸和失眠加重。患者既往无甲状腺疾病或重大家族史。检查显示窦性心动过速,无甲状腺肿或震颤。实验室结果证实甲亢,TSH水平被抑制(0.03 mlU/L),游离T4水平升高(20.8 pmol/L)。促甲状腺素受体抗体阴性,排除格雷夫斯病。停用利拉鲁肽,并用卡马唑和心得安治疗,患者在数周内症状缓解,甲状腺功能恢复正常。利拉鲁肽诱导的甲状腺功能障碍尚不清楚。可能的机制包括GLP-1受体在甲状腺组织中的活性,下丘脑-垂体-甲状腺轴的破坏或甲状腺滤泡细胞的炎症。本病例表明利拉鲁肽的使用和甲亢之间有很强的时间相关性,停药后就消失了。虽然GLP-1 RAs引起的甲状腺功能障碍已在临床前研究中被注意到,但人体数据仍然有限。本病例突出了利拉鲁肽罕见的不良反应,并强调了在监测GLP-1 RAs患者时需要保持警惕。有症状的患者应考虑监测甲状腺功能。为了更好地了解GLP-1 ra诱导的甲状腺异常的潜在机制和患病率,需要进一步的研究。
{"title":"Suspected liraglutide (glucagon-like peptide-1 receptor agonist)-induced hyperthyroidism: A case report.","authors":"Siti Nur Syakinah Md Sabudin, Lili Husniati Yaacob, Muhammad Rahmat Che Omar","doi":"10.51866/cr.886","DOIUrl":"10.51866/cr.886","url":null,"abstract":"<p><p>Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is widely used for weight management and glycaemic control. While generally well-tolerated, various adverse effects have been reported. Thyroid dysfunction, particularly hyperthyroidism, is rare. This report describes the case of a 34-year-old woman with new-onset hyperthyroidism following liraglutide use for weight loss. The patient presented with worsening palpitations and insomnia after 3 weeks of liraglutide use. She had no prior thyroid disease or significant family history. Examination revealed sinus tachycardia with no goitre or tremors. Laboratory findings confirmed hyperthyroidism with a suppressed TSH level (0.03 mlU/L) and an elevated free T4 level (20.8 pmol/L). Thyrotropin receptor antibody was negative, ruling out Graves' disease. Liraglutide was discontinued, and the patient was treated with carbimazole and propranolol, resulting in symptom resolution and normalisation of thyroid function within weeks. Liraglutide-induced thyroid dysfunction is poorly understood. Possible mechanisms include GLP-1 receptor activity in thyroid tissue, disruption of the hypothalamic-pituitary-thyroid axis or inflammation of thyroid follicular cells. This case demonstrates a strong temporal association between liraglutide use and hyperthyroidism, which resolved upon drug discontinuation. Although thyroid dysfunction with GLP-1 RAs has been noted in preclinical studies, human data remain limited. This case highlights a rare adverse effect of liraglutide and underscores the need for vigilance when monitoring patients on GLP-1 RAs. Monitoring of thyroid function should be considered in symptomatic patients. Further research is warranted to better understand the underlying mechanisms and prevalence of GLP-1 RA-induced thyroid abnormalities.</p>","PeriodicalId":40017,"journal":{"name":"Malaysian Family Physician","volume":"20 ","pages":"58"},"PeriodicalIF":0.0,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Malaysian Family Physician
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1